ALX Oncology

-$3.27 (-5.03%) Today

$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell ALX Oncology and other stocks, options, and ETFs commission-free!

About ALXO

ALX Oncology Holdings, Inc. operates as a clinical stage company, which engages in the research and development of therapies for cancer patients. Its objective is to provide clinical therapies for the treatment of myelodysplastic syndromes, acute myeloid leukemia, and a range of solid tumor indications.

CEO

Jaume Pons

Employees

Headquarters

Burlingame, California

Founded

2015

ALXO Key Statistics

Market Cap

2.47B

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

213.86K

High Today

$64.56

Low Today

$60.26

Open Price

$64.56

Volume

184.13K

52 Week High

$117.45

52 Week Low

$28.01

Analyst Ratings

100%

of 7 ratings

Buy

100%

Hold

Sell

ALXO Earnings

-$0.43

-$0.29

-$0.14

$0.00

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Estimated

— per share

Actual

—